Quantum Biopharma (QNTM) EBIT (2019 - 2026)
Quantum Biopharma (QNTM) posted EBIT of -$3.0 million for Q1 2026, down 24.98% sequentially from -$2.4 million in Q4 2025, and up 12.69% YoY from -$2.6 million in Q1 2025.
Quantum Biopharma (QNTM) EBIT (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported EBIT for 8 years, with the latest figure at -$3.0 million in Q1 2026.
- Quarterly EBIT rose 12.69% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.9 million (down 13.29% YoY) and the FY2025 annual result came in at -$15.3 million, up 5.17% from the prior year.
- EBIT fell to -$3.0 million in Q1 2026 per QNTM's latest filing, from -$2.4 million in the prior quarter.
- Over five years, EBIT peaked at $5.6 million in Q1 2022 and troughed at -$34.8 million in Q4 2023.
- A 5-year average of -$5.6 million and a median of -$3.4 million in 2024 frame the typical range for EBIT.
- The sharpest annual moves came in 2023 and 2024: EBIT tumbled 274.26% in 2023, then soared 93.99% in 2024.
- Over 5 years, EBIT stood at $5.6 million in 2022, then sank by 716.08% to -$34.8 million in 2023, then jumped by 93.99% to -$2.1 million in 2024, then retreated by 13.48% to -$2.4 million in 2025, then decreased by 24.98% to -$3.0 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$3.0 million, -$2.4 million, and -$4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Quantum Biopharma | 15.53 Mn | 11.89 Mn | - | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.29 Mn |
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | -2.37 Mn |
| Sep 30, 2025 | -4.68 Mn |
| Jun 30, 2025 | -4.85 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | -4.18 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -34.81 Mn |
| Sep 30, 2023 | -3.31 Mn |
| Jun 30, 2023 | -5.72 Mn |
| Mar 31, 2023 | -9.84 Mn |
| Mar 31, 2022 | 5.65 Mn |
| Jun 30, 2021 | -12.69 Mn |
| Mar 31, 2021 | 9.80 Mn |
| Sep 30, 2020 | -13.12 Mn |
| Jun 30, 2020 | -3.48 Mn |
| Mar 31, 2020 | -4.99 Mn |